Skip to content
Disclosery

13F-HR filed by STEMPOINT CAPITAL LP

STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 61 holding rows worth $313,700,989.

Accession
0001420506-25-001189
Filer
CIK 1952142
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 62 entries on the cover page, a total value of $313,700,989 stated on the cover page (in dollars after the unit check, H1), rows summing to $313,700,989 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ROIVANT SCIENCES LTDG76279101SHS2,578,860$26,020,697dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM1,598,594$19,638,727dollars as filed
SCHOLAR ROCK HLDG CORP80706P103COM566,212$18,203,716dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock273,774$17,959,574dollars as filed
MERUS N VN5749R100COM346,756$14,594,960dollars as filed
IMMUNOVANT INC45258J102COM853,472$14,585,836dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock40,936$13,559,231dollars as filed
NUVALENT INC COM670703107Stock190,401$13,503,239dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock318,782$11,272,132dollars as filed
JANUX THERAPEUTICS INC47103J105COM342,062$9,235,674dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock274,633$9,213,937dollars as filed
DENALI THERAPEUTICS INC COM24823R105Stock667,078$9,068,925dollars as filed
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS593,335$8,532,157dollars as filed
UNIQURE NVN90064101SHS731,039$7,749,013dollars as filed
BRIDGEBIO PHARMA INC10806X102COM208,437$7,205,667dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK289,823$7,101,533dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM159,305$7,030,130dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM440,073$6,882,742dollars as filed
INSMED INC COM PAR $.01457669307Stock87,059$6,641,731dollars as filed
ALKERMES PLCG01767105SHS192,352$6,351,463dollars as filed
AKERO THERAPEUTICS INC00973Y108COM156,185$6,322,369dollars as filed
BIOHAVEN LTDG1110E107COM250,564$6,023,559dollars as filed
CYTOKINETICS INC23282W605COM NEW149,648$6,014,353dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM61,927$5,481,159dollars as filed
VISTAGEN THERAPEUTICS INC92840H400COM2,366,554$5,111,689dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK1,190,579$5,071,867dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM386,837$4,464,099dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM180,255$3,965,610dollars as filed
SURROZEN INC86889P208COMMON STOCK240,826$2,808,031dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM49,241$2,381,295dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock120,430$2,370,062dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM21,052$2,328,351dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR14,732$2,296,130dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS200,900$2,270,170dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW136,139$2,196,603dollars as filed
AMICUS THERAPEUTICS INC03152W109COM268,919$2,194,379dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK104,585$2,140,855dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM33,816$1,791,234dollars as filed
Arbutus Biopharma Corp03879J100Common Shares, without par value467,882$1,632,908dollars as filed
PERCEPTIVE CAPITAL SOLUTIONSG70077105CL A ORD SHS150,000$1,545,000dollars as filed
GERON CORP374163103COM960,307$1,526,888dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock66,999$1,097,444dollars as filed
ZAI LAB LTD ADR98887Q104ADR26,421$954,855dollars as filed
OCULAR THERAPEUTIX INC67576A100COM124,523$912,754dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock84,430$883,138dollars as filed
SOLENO THERAPEUTICS INC834203309COM11,155$797,025dollars as filed
Inflarx NvN44821101COM725,019$739,519dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK198,150$733,155dollars as filed
WAVE LIFE SCIENCES LTD SHSY95308105Stock89,833$725,851dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock96,615$713,019dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK60,000$627,600dollars as filed
BICARA THERAPEUTICS INC055477103COM47,078$613,426dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM50,000$237,500dollars as filedput
CVS Health Corporation126650100COM64,100$165,058dollars as filedput
MINERALYS THERAPEUTICS INC603170101COM125,000$93,750dollars as filedput
ARCUTIS BIOTHERAPEUTICS INC03969K108COM100,000$42,500dollars as filedcall
KALVISTA PHARMACEUTICALS INC483497103COM100,000$32,500dollars as filedcall
ETFIS SER TR I26923G301VIRTUS LIFESC CT132,500$16,563dollars as filedcall
RHYTHM PHARMACEUTICALS INC76243J105COM10,000$15,500dollars as filedcall
Merck & Co.,Inc.58933Y105COM151,700$8,344dollars as filedcall
NOVO-NORDISK A S ADR670100205ADR151,700$3,793dollars as filedcall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-25-001189this filing2025-05-15acceptance time not in the bulk data set